Autologous stem-cell transplantation as first-line therapy in peripheral T-cell lymphomas: results of a prospective multicenter study
about
Advancement in high dose therapy and autologous stem cell rescue in lymphomaConsolidative autologous hematopoietic stem-cell transplantation in first remission for non-Hodgkin lymphoma: current indications and future perspectiveT-cell lymphomas, a challenging disease: types, treatments, and future.Treatment of peripheral T-cell lymphoma: are we data driven or driving the data?Multicentre phase II study of the CyclOBEAP regimen for patients with peripheral T-cell lymphoma with analysis of biomarkers.Bevacizumab and cyclosphosphamide, doxorubicin, vincristine and prednisone in combination for patients with peripheral T-cell or natural killer cell neoplasms: an Eastern Cooperative Oncology Group study (E2404).Phase II study of HCVIDD/MA in patients with newly diagnosed peripheral T-cell lymphoma.A phase II study of cyclophosphamide, etoposide, vincristine and prednisone (CEOP) Alternating with Pralatrexate (P) as front line therapy for patients with peripheral T-cell lymphoma (PTCL): final results from the T- cell consortium trial.Bendamustine for the treatment of relapsed or refractory peripheral T cell lymphomas: A French retrospective multicenter studyOutcomes of related donor HLA-identical or HLA-haploidentical allogeneic blood or marrow transplantation for peripheral T cell lymphomaLong-term survival in patients with peripheral T-cell non-Hodgkin lymphomas after allogeneic hematopoietic stem cell transplant.Should eligible patients with T-cell lymphoma receive high-dose therapy and autologous stem cell transplant in the upfront setting?Thalidomide plus chemotherapy exhibit enhanced efficacy in the clinical treatment of T-cell non-Hodgkin's lymphoma: A prospective study of 46 cases.Brentuximab vedotin in the front-line treatment of patients with CD30+ peripheral T-cell lymphomas: results of a phase I studyPeripheral T-cell lymphoma: review and updates of current management strategiesTreatment of High-Risk T-NHL with Stem Cell Transplantation: A Single Center Experience.Autologous stem cell transplantation as the first-line treatment for peripheral T cell lymphoma: results of a comprehensive meta-analysis.A large single-center experience with allogeneic stem-cell transplantation for peripheral T-cell non-Hodgkin lymphoma and advanced mycosis fungoides/Sezary syndrome.Primary treatment response rather than front line stem cell transplantation is crucial for long term outcome of peripheral T-cell lymphomas.Prognostic significance of interim PET/CT based on visual, SUV-based, and MTV-based assessment in the treatment of peripheral T-cell lymphoma.Comparison of survival in patients with T cell lymphoma after autologous and allogeneic stem cell transplantation as a frontline strategy or in relapsed disease.Objective responses in relapsed T-cell lymphomas with single-agent brentuximab vedotin.An update on the management of peripheral T-cell lymphoma and emerging treatment optionsNew developments in the treatment of peripheral T-cell lymphoma - role of Belinostat.How I treat the peripheral T-cell lymphomasRomidepsin for the Treatment of Peripheral T-Cell Lymphoma.Safety and efficacy of pralatrexate in the management of relapsed or refractory peripheral T-cell lymphomaHow to predict the outcome in mature T and NK cell lymphoma by currently used prognostic models?Phase 2 trial of combined cisplatin, etoposide, gemcitabine, and methylprednisolone (PEGS) in peripheral T-cell non-Hodgkin lymphoma: Southwest Oncology Group Study S0350.Targeting intratumoral B cells with rituximab in addition to CHOP in angioimmunoblastic T-cell lymphoma. A clinicobiological study of the GELAHigh-dose therapy and autologous hematopoietic cell transplantation in peripheral T cell lymphoma (PTCL): analysis of prognostic factors.Evolving Therapy of Peripheral T-cell Lymphoma: 2010 and beyond.Autologous stem cell transplantation as consolidation therapy for patients with peripheral T cell lymphoma in first remission: long-term outcome and risk factors analysis.Adult systemic anaplastic large-cell lymphoma: recommendations for diagnosis and managementHematopoietic cell transplantation for systemic mature T-cell non-Hodgkin lymphoma.CHO(E)P-14 followed by alemtuzumab consolidation in untreated peripheral T cell lymphomas: final analysis of a prospective phase II trial.First-line therapy of peripheral T-cell lymphoma: extension and long-term follow-up of a study investigating the role of autologous stem cell transplantation.Strategies for relapsed peripheral T-cell lymphoma: the tail that wags the curve.Controversies in the treatment of lymphoma with autologous transplantation.Comparison of Total Body Irradiation (TBI) Conditioning with Non-TBI for Autologous Stem Cell Transplantation in Newly Diagnosed or Relapsed Mature T- and NK-Cell Non-Hodgkin Lymphoma.
P2860
Q26795538-208DACC9-AC04-49F2-9C8D-294AEAF9FB3CQ26998446-00BD1E6A-3710-46CB-B7F1-4068D3940AD9Q30244553-5D7DDB2E-074C-4B36-8311-0E160BF23587Q30613674-4ADB76A8-9C13-44D4-B1D3-1298326F949FQ33394912-C3038287-094E-466B-8E68-981B41BC1218Q33408536-0F158385-712A-40AE-A011-66C1B3991B5BQ33425087-324973A7-F507-45D5-A3E3-0F7E4A86B370Q33428066-79851AC2-C9EF-42F1-97F1-541724291F2EQ33434137-24EAABDB-1160-43D2-9CEC-7743C4681CEBQ33608520-6546A2A0-5BAE-415F-9895-64233A628487Q33745878-DBD7A317-C532-4725-B520-87066D3F9C3FQ33822764-133A5703-4024-4FBB-9BCC-928352C78F3BQ33932989-31CC2F65-67DB-4881-9C9A-E41F8C9351DBQ34226010-AB0388EA-8502-495C-B61C-B2A49D536E31Q34479082-C95F0893-6E12-4F5E-AC4D-135C21F6430AQ34766846-C8E5AB4D-11D6-4557-855A-1B33134BA3D4Q35025993-9388B260-02C5-40D3-965C-85D300C10842Q35064713-FC4B5F1E-BE10-4668-894C-C907A385657EQ35224833-822AB1B0-AB9D-4C4C-94BE-A0DA415B1A27Q35232775-CE9E146A-2DAA-4DDD-B1BE-5E06FA0179AEQ35533531-C2EF917F-0EB9-49B9-976D-5A0218CB8CE2Q35586880-70FB8681-DA83-4B39-A399-D13CE4DBB280Q35683871-58FC5669-5AF9-4D4B-8298-C4933884956DQ35703714-4E6CFD34-82B5-4C38-8A61-D9E6B6EE2084Q35865090-B065C528-DB97-43EE-8F3F-09301D742EB1Q36064937-7E2951FB-091E-4417-A3BD-CF60DA93F152Q36283958-77EDAC52-EB87-4DC8-972D-42BAE22CE324Q36355093-453ED081-09D9-4D68-AA2F-2D7FA7481330Q36360736-69E76C5D-CB58-42E7-8304-43DF4769DB0DQ36366982-9128DD97-8012-4D5B-9BE5-AE45202710E4Q36604739-96A29EF0-83A7-46D5-A56B-E6DD40266A94Q36612584-61D2BE65-AF0D-4677-8075-882626DE4803Q36907048-580D54B9-7118-4914-9F01-F28C46FE57A0Q36926529-084C5E24-0DE3-49C6-B76E-7872168A0C42Q37122302-44312540-51CA-4F86-AA4E-B28985F3F6DFQ37214534-069E4C6F-6A5E-44E8-8D07-F11A6DF2F0B3Q37271019-34175173-B7E4-44A5-9059-74976DB975DAQ37391571-D9C90EDC-53E2-4F6E-B861-362D026F4A71Q37593800-742A318C-62D0-4048-A9B4-F2E8D0A7B9E9Q37606643-6E9F7F22-3FCD-4F45-A18C-6095CBF57D6A
P2860
Autologous stem-cell transplantation as first-line therapy in peripheral T-cell lymphomas: results of a prospective multicenter study
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Autologous stem-cell transplan ...... prospective multicenter study
@ast
Autologous stem-cell transplan ...... prospective multicenter study
@en
Autologous stem-cell transplan ...... prospective multicenter study
@nl
type
label
Autologous stem-cell transplan ...... prospective multicenter study
@ast
Autologous stem-cell transplan ...... prospective multicenter study
@en
Autologous stem-cell transplan ...... prospective multicenter study
@nl
prefLabel
Autologous stem-cell transplan ...... prospective multicenter study
@ast
Autologous stem-cell transplan ...... prospective multicenter study
@en
Autologous stem-cell transplan ...... prospective multicenter study
@nl
P2093
P50
P3181
P356
P1476
Autologous stem-cell transplan ...... prospective multicenter study
@en
P2093
Christoph Nerl
Eva Geissinger
Florian Weissinger
Martin Wilhelm
Norbert Schmitz
Peter Reimer
Thomas Rüdiger
P304
P3181
P356
10.1200/JCO.2008.17.4870
P407
P577
2009-01-01T00:00:00Z